The Peanut Allergy Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the Peanut Allergy Treatment increased from $0.45 billion in 2024 to $0.51 billion in 2025. The Compound Annual Growth Rate (CAGR) during this time was 11.4%.
The peanut allergy treatment market is anticipated to reach a market size of $0.77 billion in 2029. The projected compound annual growth rate (CAGR) is 11.1%.
Download Your Free Sample of the 2025 Peanut Allergy Treatment Market Report and Uncover Key Trends Now!The drivers in the peanut allergy treatment market are:
• High occurrence rate of peanut allergies
• Technological advancements in diagnostic testing
• Heightened public awareness and concern about the condition
• Development of early intervention strategies and regulatory approval of treatments
The peanut allergy treatment market covered in this report is segmented –
1) By Drug Class: Antihistamines, Immunotherapies, Epinephrine, Other Drug Classes
2) By Route Of Administration: Injectable, Oral, Other Routes Of Administration
3) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Other Distribution Channels
The trends in the peanut allergy treatment market are:
• The rise in the adoption of immunotherapy is influencing the peanut allergy treatment market.
• Advancements in biologic therapies are shaping the industry.
• The integration of probiotic-based treatments is a noted upcoming trend.
• There is an increasing trend for personalized medicine approaches and support from regulatory authorities.
The major players in the peanut allergy treatment market are:
• Pfizer Inc.
North America was the largest region in the peanut allergy treatment market in 2023